| |
| 長村 義之 |
国際医療福祉大学大学院 教授
国際医療福祉大学 病理診断センター長 |
| 病理学、内分泌学、腫瘍学 |
| Analysis of gene alterations of mitochondrial DNA D-loop regions to detemine breast cancer clonality. Masuda S, Kadowaki N, Tokuda Y, Yoshimura S, Takekoshi S, Osamura RY: Analysis of gene alteations of mitochondrial DNA D-loop regions to determine breast cancer clonality. BrJ Cancer 2012, 107:2016-2023 |
| Transdifferentiation of pituitary thyrotrophs to lactothyrotrophys in primary hypothyroidism: case report. Jentoft ME, Osamura RY, Kovacs K, Lloyd RV, Scheithauer BW: Virchows Arch 2012, 461:221-225 |
| DNA mismatch repair protein(MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, Isozaki O, Iwai Y, Sakata K, Fukuhara N, Nishioka H, Osamura RY, et al: J Clin Endocrinol Metab 2013,98:1130-1136 |
|
| ○ |
| 北島 政樹 |
国際医療福祉大学 学長 |
| 消化器外科 |
| Masaki Kitajima, Yuko Kitagawa: Surgical Treatment of Esophageal Cancer- The Advent of the Era of Individualization. The New England Journal of Medicine 347(21):1705-1708,2002 |
| Hiroshi Yagi, Masakazu Ueda, Hiromitsu Jinnno, Koichi Aiura, Shuji Mikami, Hiroko Tada, Masaharu Seno, Hidenori Yamada and Masaki Kitajima: Anti-tumor effect in an in vivo model by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties. Cancer Science 97(12):1315-1320, 2006 |
| Hiroya Takeuchi, MD, Hirohumi Fujii, MD, Nobutoshi Ando, MD, Soji Ozawa, MD, Yoshiro Saikawa, MD, Koichi Suda, MD, Takashi Oyama, MD, Makio Mukai, MD, Tadaki Nakahara, MD, Atsushi Kubo, MD, Masaki Kitajima, MD, and Yuko Kitagawa, MD: Validation Study of Radio-Guided Sentinel Lymph Node Navigation in Dsophageal Cancer: Annals of Surgery/Volume 249, p757-762: Number 5, May 2009 |
|
| |
| 児玉 哲郎 |
栃木県立がんセンタ-所長 |
| 臨床腫瘍学、呼吸器診断学 |
| Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. Yokozaki M, Kodama T, et al.:Modern Pathol, 9:1156-1164, 1996 |
| Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Miyake Y, Kodama T, Yamaguchi K: Cancer Res, 54:2136-2140, 1994 |
| Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Sugano K, Kodama T, et al. Cancer Sci 99:1967-1976, 2008 |
|
| |
| 高嶋 成光 |
独立行政法人国立病院機構四国がんセンター
名誉院長 |
| 乳腺外科 |
| Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer:A randomized,placebo-controlled trial. Kohno N, Aogi K,Takashima S,et al. J Clin Oncol 23:3314-3321,2005. |
Randomized trial of cyclophosphamide,epirubicin,and fluorouracil chemotherapy compared with cyclophosphamide,methotrexate,and fluorouracil with node-positive breast cancer in Japan. Kimura M,
Tominaga Y, Takashima S,et al. Breast Cancer 17:190-198,2010. |
| Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer. Ohsumi S, Inoue T, Takashima S,et al. Breast Cancer Res Treat 130:267-272,2011. |
|
| |
| 田村 和夫 |
福岡大学医学医学科 教授 |
| 臨床腫瘍学 |
Prognostic index for acute- and lymphoma-type adult T-cell leukemia/
lymphoma. Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H,
Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N,
Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H,
Jo T, Suzumiya J, Tamura K: J Clin Oncol. 30(14): 1635-40, 2012 |
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult
T-cell leukemia/lymphoma: a multicenter phase II study. Takamatsu Y,
Suzumiya J, Utsunomiya A, Maeda K, Matsuoka H, Suzushima H, Tsukada J,
Shibata K, Tamura K; the Kyushu Hematology Organization for Treatment
Study Group (K-HOT). Eur J Haematol. 84(5): 391-7, 2010 |
| Pilot study of Irinotecan and S-1 for advanced and metastatic breast cancer. Tanaka M, Furusawa H, Kamada Y, Sagara Y, Anan K, MiyaraK, Kai Y, Wakamatsu S, Uga T, Tamura K, Mitsuyama S, Kyushu Breast Cancer Study Group. San Antonio Breast Cancer Symposium 2010 |
|
| |
|
| |
| 根本 建二 |
山形大学医学部 教授 |
| 放射線腫瘍学 |
| Influence of a multidisciplinary cancer board on treatment decisions. Nemoto K, Murakami M, Ichikawa M, Ohta I, Nomiya T, Yamakawa M, Itho Y, Fukui T, Yoshioka T. Int J Clin Oncol. 2012 May; in press (online journal available). |
Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection. Nemoto K, Takai K, Ogawa Y, Sakayauchi T, Sugawara T, Jingu K, Wada H, Takai Y, Yamada S.
Int J Radiat Oncol Biol Phys. 2005 Dec;63(5):1290-1294. |
| Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Nemoto K, Yamada S, Hareyama M, Nagakura H, Hirokawa Y.Int J Radiat Oncol Biol Phys. 2001 Jul;50(3):639-644. |
|
| |
| 原 純一 |
大阪市立総合医療センター 副院長 |
| 小児血液学・腫瘍学 |
Development of treatment strategies for advanced neuroblastoma.
Hara J.
Int J Clin Oncol. 2012 Jun;17(3):196-203. |
| Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J. Medulloblastoma in young children. Pediatr Blood Cancer. 2010 Apr;54(4):635-7 |
| Hara J, Benedict SH, Yumura K, Ha-Kawa K, Gelfand EW: Rearrangement of variable region T cell receptor gamma genes in acute lymphoblastic leukemia. V gamma gene usage differs in mature and immature T cells.J Clin Invest 1989;83(4):1277-1283 |
|
